Recombinant Human DDR2 Protein，His

DDR2 (Discoidin Domain Receptor 2) is a type of receptor tyrosine kinase that plays a critical role in the regulation of various cellular processes, including cell adhesion, migration, and proliferation, particularly in response to the extracellular matrix (ECM). Its involvement in fibrotic diseases and cancer progression has garnered significant research interest, as DDR2 can modulate the behavior of fibroblasts and other cell types within the tumor microenvironment. The receptor is activated by collagen, which initiates intracellular signaling pathways that contribute to tissue remodeling and repair. Given its essential functions and the pathological implications of its dysregulation, the study of DDR2 and the development of recombinant proteins or inhibitors targeting DDR2 could provide valuable insights into therapeutic strategies for fibrotic diseases and certain cancers. By utilizing recombinant DNA technology, researchers can produce DDR2 proteins in a controlled manner, facilitating the exploration of its structural and functional properties. This research background highlights the potential of DDR2 as a target for drug development, emphasizing the need for detailed studies on its mechanisms of action and the roles it plays in health and disease. Understanding DDR2's interaction with ECM components and its downstream signaling pathways could lead to novel interventions aimed at mitigating diseases characterized by excessive fibrosis or tumor progression. As the field evolves, the investigation of DDR2 as both a biomarker and a therapeutic target will be crucial in advancing our knowledge of ECM biology and improving clinical outcomes for patients affected by related conditions.